Completed PHASE2 INTERVENTIONAL 4-arm NCT00964886

Efficacy of Antidepressants in Chronic Back Pain

Sponsor: University of California, San Diego

Conditions Back Pain

Interventions benztropine mesylate 0.125 mg daily cognitive behavioral therapy desipramine hydrochloride

Updated 6 times since 2017 Last updated: Nov 23, 2016 Started: Jan 31, 2010 Primary completion: Dec 31, 2014 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00964886, this PHASE2 trial focuses on Back Pain and remains completed. Sponsored by University of California, San Diego, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Dec 2021 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Dec 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of California, San Diego
VA Office of Research and Development

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Diego, United States